トシリズマブの投与により褥創の改善が得られた難治性関節リウマチの一例

症例は72歳女性.1999年に関節リウマチを発症し高疾患活動性が持続した.2010年2月に全身倦怠感,微熱,多関節痛で入院した.ステロイドを増量したが,感染症を繰り返し,低蛋白血症が進行し,日常生活動作が困難となり臀部に褥創をきたした.計4回のトシリズマブの投与で全身状態は改善し,それに伴い褥創も改善した.疾患活動性により全身状態が悪化した症例ではトシリズマブの投与で有効性が得られると考えられた....

Full description

Saved in:
Bibliographic Details
Published in臨床リウマチ Vol. 25; no. 2; pp. 119 - 124
Main Authors 竹田, 剛, 中川, 育磨, 武井, 望, 清水, 悠以, 小谷, 俊雄
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本臨床リウマチ学会 2013
The Japanese Society for Clinical Rheumatology and Related Research
Subjects
Online AccessGet full text
ISSN0914-8760
2189-0595
DOI10.14961/cra.25.119

Cover

Abstract 症例は72歳女性.1999年に関節リウマチを発症し高疾患活動性が持続した.2010年2月に全身倦怠感,微熱,多関節痛で入院した.ステロイドを増量したが,感染症を繰り返し,低蛋白血症が進行し,日常生活動作が困難となり臀部に褥創をきたした.計4回のトシリズマブの投与で全身状態は改善し,それに伴い褥創も改善した.疾患活動性により全身状態が悪化した症例ではトシリズマブの投与で有効性が得られると考えられた.
AbstractList     A 72-year-old woman was admitted to our hospital with complaints of general malaise, mild fever, and polyarthlargia in February 2010. She had been diagnosed as having rheumatoid arthritis in 1999, and in spite of the treatment with conventional DMARDs therapy followed by TNFαinhibitors of etenercept and adalimumab, her disease activity was not well controlled. Her Steinblocker Classification was Stage IV, and her Functional Class was Class 4.Investigations showed that her symptoms were derived from disease activity of her rheumatoid arthritis. We started 40 mg/day prednisolone, however opportunistic infection occurred, and anemia and hypoalbuminemia progressed. Her activities of daily living (ADL) worsened and a pressure ulcer appeared. Although she had some risk factors such as her age being over 65 years and being Functional Class 4, we administered Tocilizumab (TCZ) 8 mg/kg with cyclophosphamide 50 mg/day in order to control the disease activity. After the administration of TCZ, her disease activity was well controlled and anemia and hypoalubuminemia dramatically improved without any infections and adverse events. The pressure ulcer was cured and TCZ was stopped after the fourth administration.     This case suggests that TCZ can strongly suppress inflammation and improve anemia, hypoalbuminemia induced by the disease activity itself. The pressure ulcer was then cured, accompanied by improvement of ADL. Although TCZ carries an increased risk of infections, TCZ can be used carefully for the treatment of severe rheumatoid arthritis with some risk factors.    症例は72歳女性.1999年に関節リウマチを発症し高疾患活動性が持続した.2010年2月に全身倦怠感,微熱,多関節痛で入院した.ステロイドを増量したが,感染症を繰り返し,低蛋白血症が進行し,日常生活動作が困難となり臀部に褥創をきたした.計4回のトシリズマブの投与で全身状態は改善し,それに伴い褥創も改善した.疾患活動性により全身状態が悪化した症例ではトシリズマブの投与で有効性が得られると考えられた.
症例は72歳女性.1999年に関節リウマチを発症し高疾患活動性が持続した.2010年2月に全身倦怠感,微熱,多関節痛で入院した.ステロイドを増量したが,感染症を繰り返し,低蛋白血症が進行し,日常生活動作が困難となり臀部に褥創をきたした.計4回のトシリズマブの投与で全身状態は改善し,それに伴い褥創も改善した.疾患活動性により全身状態が悪化した症例ではトシリズマブの投与で有効性が得られると考えられた.
Author 中川, 育磨
武井, 望
小谷, 俊雄
清水, 悠以
竹田, 剛
Author_FL Odani Toshio
Nakagawa Ikuma
Takeda Tsuyoshi
Takei Nozomu
Shimizu Yui
Author_FL_xml – sequence: 1
  fullname: Takei Nozomu
– sequence: 2
  fullname: Shimizu Yui
– sequence: 3
  fullname: Nakagawa Ikuma
– sequence: 4
  fullname: Odani Toshio
– sequence: 5
  fullname: Takeda Tsuyoshi
Author_xml – sequence: 1
  fullname: 竹田, 剛
  organization: 帯広厚生病院第三内科
– sequence: 1
  fullname: 中川, 育磨
  organization: 帯広厚生病院第三内科
– sequence: 1
  fullname: 武井, 望
  organization: 帯広厚生病院第三内科
– sequence: 1
  fullname: 清水, 悠以
  organization: 帯広厚生病院第三内科
– sequence: 1
  fullname: 小谷, 俊雄
  organization: 帯広厚生病院第三内科
BackLink https://cir.nii.ac.jp/crid/1390001204341818368$$DView record in CiNii
BookMark eNpFkM1Kw0AUhQepYK1d-QpuU-dOJmlm4UKKf1Bwo-swSWY0pVZJunHXpC5sLa60LgQFf0FBQRCrQl9m2mrfwtQKbs6Fc8_94J5plKrsVgRCs4BzQJkJ827Ac8TIAbAJlCZgMQ0bzEihNGZANStv4imUDUPfwZhiDMwiaSRV_VDFb6r-oOIPVb9Q9baKngbN017nWEWPKk62ze-b237jdeSfvPfbBypq9btnKm6ouKWiy-H59eDlc1C7H7avvp5rv6i7X1SUnPQ6tV73aAZNSl4ORfZvZtDm8tJGYVUrrq-sFRaLWono2NIE9wBAcmJi5hmG40hDmAw83TFdIsHzpMhjAZQzCp6kjiQYe9w1HU4psRjoGTQ35lZ833b9kYLOcPItwVSnYIGlm1YSWxjHSmGVbwl7L_B3eLBv86Dqu2VhJ03axLDJSJI6__1tHtglrv8AoKeQcA
ContentType Journal Article
Copyright 2013 一般社団法人日本臨床リウマチ学会
Copyright_xml – notice: 2013 一般社団法人日本臨床リウマチ学会
DBID RYH
DOI 10.14961/cra.25.119
DatabaseName CiNii Complete
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Successful treatment of pressure ulcer with Tocilizumab in a case of severe rheumatoid arthritis
DocumentTitle_FL Successful treatment of pressure ulcer with Tocilizumab in a case of severe rheumatoid arthritis
EISSN 2189-0595
EndPage 124
ExternalDocumentID 130005094934
article_cra_25_2_25_119_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
RJT
RYH
ID FETCH-LOGICAL-j2308-ead111fa2609d55bbf5e691d3b6c2f1ddfe70e14a941df4bf200dac6ba4428913
ISSN 0914-8760
IngestDate Thu Jun 26 22:27:42 EDT 2025
Wed Sep 03 06:00:52 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 2
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2308-ead111fa2609d55bbf5e691d3b6c2f1ddfe70e14a941df4bf200dac6ba4428913
OpenAccessLink https://www.jstage.jst.go.jp/article/cra/25/2/25_119/_article/-char/ja
PageCount 6
ParticipantIDs nii_cinii_1390001204341818368
jstage_primary_article_cra_25_2_25_119_article_char_ja
PublicationCentury 2000
PublicationDate 2013
PublicationDateYYYYMMDD 2013-01-01
PublicationDate_xml – year: 2013
  text: 2013
PublicationDecade 2010
PublicationTitle 臨床リウマチ
PublicationTitleAlternate 臨床リウマチ
PublicationTitle_FL Clinical Rheumatology and Related Research
臨床リウマチ
PublicationYear 2013
Publisher 一般社団法人 日本臨床リウマチ学会
The Japanese Society for Clinical Rheumatology and Related Research
Publisher_xml – name: 一般社団法人 日本臨床リウマチ学会
– name: The Japanese Society for Clinical Rheumatology and Related Research
References 5) Lin, Z.Q., Kondo, T., Ishida, Y. et al.: Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in Il-6-dificient mice. J. Leukoc. Biol., 73: 713-721, 2003.
6) Nishimoto, N.: Inerleukin-6 in rheumatoid arthtitis. Curr. Opin. Rheumatol., 18: 277-281, 2006.
7) Nishimoto, N., Ito K., Takagi, N.: Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions. Mod. Rheumatol., 20: 222-232, 2010.
1) Gallucci, R.M., Sugawara, T., Yucesoy, B. et al.: Interleukin-6 treatment augments cutaneous wound healing in immunosuppressed mice. J. Interferon Cytokine Res., 21: 603-609, 2001.
2) Hashizume, M., Uchiyama, Y., Horai, N., et al.: Tocilizumab, a humanized antiinterleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production. Rheumatol. Int., 30: 917-923, 2010.
4) Koike, R., Harigai, M., Atsumi, T., et al.: Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis. Mod. Rheumatol., 19: 351-357, 2009.
8) Nishimoto, N., Terao, K., Mima, T., et al.: Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood, 112: 3959-3964, 2008.
3) Iizaka, S., Sanada, H., Matsui, Y., et al.: Serum albumin level is a limited nutritional marker for predicting wound healing in patients with pressure ulcer: Two multicenter prospective cohort studies. Clin. nurt., 30: 738-745, 2011.
References_xml – reference: 2) Hashizume, M., Uchiyama, Y., Horai, N., et al.: Tocilizumab, a humanized antiinterleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production. Rheumatol. Int., 30: 917-923, 2010.
– reference: 6) Nishimoto, N.: Inerleukin-6 in rheumatoid arthtitis. Curr. Opin. Rheumatol., 18: 277-281, 2006.
– reference: 3) Iizaka, S., Sanada, H., Matsui, Y., et al.: Serum albumin level is a limited nutritional marker for predicting wound healing in patients with pressure ulcer: Two multicenter prospective cohort studies. Clin. nurt., 30: 738-745, 2011.
– reference: 1) Gallucci, R.M., Sugawara, T., Yucesoy, B. et al.: Interleukin-6 treatment augments cutaneous wound healing in immunosuppressed mice. J. Interferon Cytokine Res., 21: 603-609, 2001.
– reference: 8) Nishimoto, N., Terao, K., Mima, T., et al.: Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood, 112: 3959-3964, 2008.
– reference: 5) Lin, Z.Q., Kondo, T., Ishida, Y. et al.: Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in Il-6-dificient mice. J. Leukoc. Biol., 73: 713-721, 2003.
– reference: 4) Koike, R., Harigai, M., Atsumi, T., et al.: Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis. Mod. Rheumatol., 19: 351-357, 2009.
– reference: 7) Nishimoto, N., Ito K., Takagi, N.: Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions. Mod. Rheumatol., 20: 222-232, 2010.
SSID ssib004001982
ssj0003304618
ssib029852172
ssib058494229
Score 1.9036691
Snippet ...
    A 72-year-old woman was admitted to our hospital with complaints of general malaise, mild fever, and polyarthlargia in February 2010. She had been...
SourceID nii
jstage
SourceType Publisher
StartPage 119
SubjectTerms anemia
hypoalbuminemia
pressure ulcer
rheumatoid arthritis
tocilizumab
Title トシリズマブの投与により褥創の改善が得られた難治性関節リウマチの一例
URI https://www.jstage.jst.go.jp/article/cra/25/2/25_119/_article/-char/ja
https://cir.nii.ac.jp/crid/1390001204341818368
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 臨床リウマチ, 2013/06/30, Vol.25(2), pp.119-124
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Pa9RAFA9tvXgRRcWqlR6cU9l1M5lJZo6TbZaiKCgt9BaSTUK7h1ZKe_HU3fVga_Gk9SAo-BcUFASxKvTLpK3WT-F7k2STVqEqLMPsmze_fW9mM_NmMm-eYVymgWShZFHN5AIWKE4U10IzhAcvjEOMbcvtNm4NXL9hT82wq7N8dmj4Z-XU0spyWG_f-aNfyf_0KtCgX9FL9h96dgAKBMhD_0IKPQzpX_Ux8Swi4CN0hhLXySlKFRSVU6RXZGydMYkCik2EIpITjxFXEOEVRW5efYAMbJ4gihEFzJwISVx-AEcCgsQiwBcsLxJNpLgekU6BI4tMM-eRLeJJIl2iLMRxQWZXC9YgytFFNlGUeA5RLSQeUlDZhxUEzFKwTK-GznhEuFVbHDUSACu0kErreDR48Q9FGdWkZmFYW_IJ3Q5N0KXKg7_PdaZBXKZ5EDkTCbTmJbMWFjBRHIfIyQktIcU2QfVBMFEycwQULWRBZGdC129pLXR7ZjHxih2dzBW3PvAGBBsJY48eOLXbLLxkb83FK7CSKa_n0kcm42hwTrO6wWsynOuyt16xpoE9J2tgUPPq_Jc5nufPOa1MZmY-mWV2kZn5uv825TJp45zbXgrqlNcHdQ7cYY7vTPGiISYtNmwco45j4vHbazdFdS4xZXnPEpWCY-y04jvYyZLR3JRHK8vSoQK0oVUomrvfokBXSnHAtOzAQgtv0BhemJ-vWI_TJ40T-bJvXGXP8CljqBOcNpK0fy_tfU77b9Pe17T_NO1vpt33e-uPdrYepN13aQ9K13-8fLW79gnpD7_sbt5Nuxu724_T3lra20i7z_afvNj7-G1v9c3-5vPvH1Y11GsN1YUqO1urO9v3zxgzLW-6OVXL457UOtRqiBoM7mCBJAG1GzLiPAwTHtvSjKzQbtPEjKIkdhqxyWCYNaOEhQmMiVHQtsOAMYrHDs4aIwuLC_E5YzyWMomkmUSxA4V4D0hgxUlkxQFlluWYo4adNY5_O7vcxs8HMx8a0Kfcp5hAK5b0uWDJ7wSjxhg0pt-exxRWkXpHu8HAJoYVgGWL80eUXzCOUx1YBjczLxojy0sr8RiY98vhJf2_-AVYoNLr
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E3%83%88%E3%82%B7%E3%83%AA%E3%82%BA%E3%83%9E%E3%83%96%E3%81%AE%E6%8A%95%E4%B8%8E%E3%81%AB%E3%82%88%E3%82%8A%E8%A4%A5%E5%89%B5%E3%81%AE%E6%94%B9%E5%96%84%E3%81%8C%E5%BE%97%E3%82%89%E3%82%8C%E3%81%9F%E9%9B%A3%E6%B2%BB%E6%80%A7%E9%96%A2%E7%AF%80%E3%83%AA%E3%82%A6%E3%83%9E%E3%83%81%E3%81%AE%E4%B8%80%E4%BE%8B&rft.jtitle=%E8%87%A8%E5%BA%8A%E3%83%AA%E3%82%A6%E3%83%9E%E3%83%81&rft.au=%E6%AD%A6%E4%BA%95+%E6%9C%9B&rft.au=%E6%B8%85%E6%B0%B4+%E6%82%A0%E4%BB%A5&rft.au=%E4%B8%AD%E5%B7%9D+%E8%82%B2%E7%A3%A8&rft.au=%E5%B0%8F%E8%B0%B7+%E4%BF%8A%E9%9B%84&rft.date=2013&rft.pub=The+Japanese+Society+for+Clinical+Rheumatology+and+Related+Research&rft.issn=0914-8760&rft.eissn=2189-0595&rft.volume=25&rft.issue=2&rft.spage=119&rft.epage=124&rft_id=info:doi/10.14961%2Fcra.25.119&rft.externalDocID=130005094934
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0914-8760&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0914-8760&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0914-8760&client=summon